In 1938, Lilly established its operations in Johannesburg, South Africa and has been committed since then to contribute to make life better for South African people. Lilly South Africa has developed its operations to cover most of Sub-Saharan Africa territories with customised solutions that are meaningful to people with chronic diseases, mainly diabetes and cancer. Lilly SASSA is committed to expanding access to medicines and healthcare, and we work with partners to improve health outcomes for people in need. We are putting a special focus on improving the health of people in targeted communities, specifically by tackling several tenacious and rapidly growing diseases such as tuberculosis and diabetes. Elanco, the Animal Health business division of Lilly, has been operating in South Africa since 1964. Elanco‘s mission is to make life sciences work better for people by transforming protein production and companion animal care.